Abeona’s deal value is in line with recent voucher sale transactions amid uncertain times in rare disease drug development.

GlobalData analysis predicts the global GLP-1RA market will reach $168bn by 2033, with Novo Nordisk and Eli Lilly to dominate ...

The UK MHRA has approved AstraZeneca's Trixeo Aerosphere inhaler to treat adults with chronic obstructive pulmonary disease ...

The new site will support Roche and its unit Genentech's future portfolio of next-generation obesity medicines.

Minghui Pharmaceutical has announced an exclusive licensing and partnership agreement with Qilu Pharmaceutical for MHB088C in ...

The Danish multinational said that Sogroya improved the yearly growth rate in pre-pubertal children born small for ...

The executive order aims to cut US prescription drug costs by linking them to the lowest prices paid internationally.

Isolator lines present several significant advantages for large-scale aseptic filling, as Marcel Langner of IDT Biologika ...

LENZ has announced an exclusive licensing and commercialisation agreement with Lotus Pharmaceutical of Taiwan.

Both the FDA and EMA have suspended Ixchiq’s use in older adults after post-marketing serious adverse events that include two ...

Eli Lilly and Purdue University, US, have announced the widening of their existing partnership with a planned investment of ...

AAN conference featured the latest research and developments in neurological disorders like Alzheimer's disease, epilepsy and ...